|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Assets segregated for regulatory purposes | ||||||||||||||||||||
| Securities purchased under agreements to resell | ||||||||||||||||||||
| Securities: | ||||||||||||||||||||
| Trading, at fair value | ||||||||||||||||||||
| Available for sale, at fair value, net (amortized cost of $1,477,022 and $1,554,096, respectively) | ||||||||||||||||||||
| Held to maturity, at amortized cost, net (fair value of $653,508 and $674,890, respectively) | ||||||||||||||||||||
| Equity, at fair value | ||||||||||||||||||||
| Total securities | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans held for investment, net of unearned income | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans held for investment, net | ||||||||||||||||||||
| Broker-dealer and clearing organization receivables | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Mortgage servicing rights | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Broker-dealer and clearing organization payables | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Securities sold, not yet purchased, at fair value | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Hilltop stockholders' equity: | ||||||||||||||||||||
| Common stock, $0.01 par value, 125,000,000 shares authorized; 56,789,014 and 59,540,484 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Deferred compensation employee stock trust, net | ||||||||||||||||||||
| Employee stock trust (0 and 10,290 shares, at cost, at December 31, 2024 and December 31, 2023, respectively) | ||||||||||||||||||||
| Total Hilltop stockholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
